Cases 61 - 70 of 926
BAKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06466
Plaintiff:
DERWIN BAKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ENANDER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06383
Plaintiff:
MARK ENANDER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TSAKALAS v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06294
Plaintiff:
DEBORAH TSAKALAS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OVERTON v. MYLAN LABORATORIES LTD. et al
as 1:2022cv05859
Plaintiff:
JOANNE OVERTON
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CAPOBIANCO v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv05685
Plaintiff:
LINDA CAPOBIANCO
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CZAJKOWSKI v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv05582
Plaintiff:
MARK DAVID CZAJKOWSKI and MARK CZAJKOWSKI
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICALS, LTD., A-S MEDICATION SOLUTIONS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Exelixis, Inc. v. Teva Pharmaceutical Industries Limited et al
as 1:2022cv01168
Plaintiff:
Exelixis, Inc.
Defendant:
Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PATTERSON v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv04935
Plaintiff:
MICHELLE PATTERSON
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S., INC., PRINSTON PHARMACEUTICAL, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GAST v. JANSSEN PHARMACEUTICALS, INC.
as 2:2022cv04865
Plaintiff:
MARY GAST
Defendant:
JANSSEN PHARMACEUTICALS, INC., f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., f/k/a JANSSEN PHARMACEUTICA, INC., ORTHO-MCNEIL PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
